Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
According to Baxter's latest financial reports the company's current revenue (TTM ) is โน1.095 Trillion. a decrease over the revenue in the year 2023 that were of โน1.140 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | โน1.102 T | -3.33% |
2023 | โน1.140 T | -6.83% |
2022 | โน1.224 T | 28.68% |
2021 | โน951.52 B | 11.46% |
2020 | โน853.69 B | 5.36% |
2019 | โน810.23 B | 4.2% |
2018 | โน777.60 B | 15.32% |
2017 | โน674.32 B | -2.36% |
2016 | โน690.62 B | 4.26% |
2015 | โน662.42 B | -31.16% |
2014 | โน962.26 B | 2.51% |
2013 | โน938.74 B | 20.83% |
2012 | โน776.94 B | 5.72% |
2011 | โน734.93 B | 27.71% |
2010 | โน575.49 B | -1.27% |
2009 | โน582.87 B | -1.79% |
2008 | โน593.50 B | 34.27% |
2007 | โน442.01 B | -3.83% |
2006 | โน459.64 B | 3.71% |
2005 | โน443.20 B | 7.62% |
2004 | โน411.81 B | 1.46% |
2003 | โน405.89 B | 5.34% |
2002 | โน385.31 B | 4.21% |
2001 | โน369.75 B | 14.88% |
2000 | โน321.84 B | 16.04% |
1999 | โน277.35 B | 6.06% |
1998 | โน261.49 B | 8.4% |
1997 | โน241.22 B | 23.39% |
1996 | โน195.49 B |